Page 27 - Read Online
P. 27

Balistreri. Vessel Plus 2018;2:25  I  http://dx.doi.org/10.20517/2574-1209.2018.35                                                      Page 9 of 10

               4.   Guignabert C, Tu L, Girerd B, Ricard N, Huertas A, Montani D, Humbert M. New molecular targets of pulmonary vascular remodeling
                   in pulmonary arterial hypertension: importance of endothelial communication. Chest 2015;147:529-37.
               5.   Batton KA, Austin CO, Bruno KA, Burger CD, Shapiro BP, Fairweather D. Sex differences in pulmonary arterial hypertension: role of
                   infection and autoimmunity in the pathogenesis of disease. Biol Sex Differ 2018;9:15.
               6.   Machado RD, Southgate L, Eichstaedt CA, Aldred MA, Austin ED, Best DH, Chung WK, Benjamin N, Elliott CG, Eyries M,
                   Fischer C, Gräf S, Hinderhofer K, Humbert M, Keiles SB, Loyd JE, Morrell NW, Newman JH, Soubrier F, Trembath RC, Viales RR,
                   Grünig E. Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects. Hum Mutat
                   2015;36:1113-27.
               7.   Gao Y, Cornfield DN, Stenmark KR, Thébaud B, Abman SH, Raj JU. Unique aspects  of the developing lung circulation: structural
                   development and regulation of vasomotor tone. Pulm Circ 2016;6:407-25.
               8.   Barker DJ. The developmental origins of adult disease. J Am Coll Nutr 2004;23:588S-95S.
               9.   Keverne EB. Genomic imprinting, action, and interaction of maternal and fetal genomes. Proc Natl Acad Sci U S A 2015;112:6834-40.
               10.  Balistreri CR (Ed.). Endothelial progenitor cells (EPCs) in ageing and age-related diseases: from their physiological and pathological
                   implications to translation in personalized medicine. Mech Ageing Dev 2016;159:1-80.
               11.  Balistrieri CR. Endothelial progenitor cells. Basel: Springer International Publishing; 2017. p. 1-80.
               12.  Regina C, Panatta E, Candi E, Melino G, Amelio I, Balistreri CR, Annicchiarico-Petruzzelli M, Di Daniele N, Ruvolo G. Vascular
                   ageing and endothelial cell senescence: molecular mechanisms of physiology and diseases. Mech Ageing Dev 2016;159:14-21.
               13.  Madonna R, Novo G, Balistreri CR. Cellular and molecular basis of the imbalance between vascular damage and repair in ageing and
                   age-related diseases: as biomarkers and targets for new treatments. Mech Ageing Dev 2016;159:22-30.
               14.  Pearce WJ, Khorram O. Maturation and differentiation of the fetal vasculature. Clin Obstet Gynecol 2013;56:537-48.
               15.  Adeoye OO, Bouthors V, Hubbell MC, Williams JM, Pearce WJ. VEGF receptors mediate hypoxic remodeling of adult ovine carotid
                   arteries. J Appl Physiol (1985) 2014;117:777-87.
               16.  Yzydorczyk C, Armengaud JB, Peyter AC, Chehade H, Cachat F, Juvet C, Siddeek B, Simoncini S, Sabatier F, Dignat-George
                   F, Mitanchez D, Simeoni U. Endothelial  dysfunction in individuals born after fetal growth restriction: cardiovascular and renal
                   consequences and preventive approaches. J Dev Orig Health Dis 2017;8:448-64.
               17.  Muñoz-Muñoz EC, Krause BJ, Uauy R, Casanello P. LGA-newborn from patients with pregestational obesity present reduced
                   adiponectin-mediated vascular relaxation and endothelial dysfunction in fetoplacental arteries. J Cell Physiol 2018;233:6723-33.
               18.  Oliveira V, de Souza LV, Fernandes T, Junior SDS, de Carvalho MHC, Akamine EH, Michelini LC, de Oliveira EM, Franco MDC.
                   Intrauterine growth restriction-induced deleterious adaptations in endothelial progenitor cells: possible mechanism to impair endothelial
                   function. J Dev Orig Health Dis 2017;8:665-73.
               19.  Menendez-Castro C, Rascher W, Hartner A. Intrauterine growth restriction-impact on cardiovascular diseases later in life. Mol Cell
                   Pediatr 2018;5:4.
               20.  Musa MG, Torrens C, Clough GF. The microvasculature: a target for nutritional  programming and later risk of cardio-metabolic
                   disease. Acta Physiol (Oxf) 2014;210:31-45.
               21.  Berger J, Bhandari V. Animal models of bronchopulmonary dysplasia. The term mouse models. Am J Physiol Lung Cell Mol Physiol
                   2014;307:L936-47.
               22.  Papamatheakis DG, Chundu M, Blood AB, Wilson SM. Prenatal programming of pulmonary hypertension induced by chronic hypoxia
                   or ductal ligation in sheep. Pulm Circ 2013;3(4):757-80.
               23.  Blood AB, Terry MH, Merritt TA, Papamatheakis DG, Blood Q, Ross JM, Power GG, Longo LD, Wilson SM. Effect of chronic
                   perinatal hypoxia on the role of rho-kinase in pulmonary artery contraction in newborn lambs. Am J Physiol Regul Integr Comp Physiol
                   2013;304:R136-46.
               24.  Fediuk J, Sikarwar AS, Nolette N, Dakshinamurti S. Thromboxane-induced actin polymerization in hypoxic neonatal pulmonary arterial
                   myocytes involves Cdc42 signaling. Am J Physiol Lung Cell Mol Physiol 2014;307:L877-87.
               25.  Yang Q, Lu Z, Ramchandran R, Longo LD, Raj JU. Pulmonary artery smooth muscle cell proliferation and migration in fetal lambs
                   acclimatized to high-altitude long-term hypoxia: role of histone acetylation. Am J Physiol Lung Cell Mol Physiol 2012;303:L1001-10.
               26.  Yee M, White RJ, Awad HA, Bates WA, McGrath-Morrow SA, O’Reilly MA. Neonatal hyperoxia causes pulmonary vascular disease
                   and shortens life span in aging mice. Am J Pathol 2011;178:2601-10.
               27.  Goss KN, Cucci AR, Fisher AJ, Albrecht M, Frump A, Tursunova R, Gao Y, Brown MB, Petrache I, Tepper RS, Ahlfeld SK, Lahm T.
                   Neonatal hyperoxic lung injury favorably alters adult right ventricular remodeling response to chronic hypoxia exposure. Am J Physiol
                   Lung Cell Mol Physiol 2015;308:L797-806.
               28.  Scherrer U, Allemann Y, Rexhaj E, Rimoldi SF, Sartori C. Mechanisms and drug therapy of pulmonary hypertension at high altitude.
                   High Alt Med Biol 2013;14:126-33.
               29.  Allemann Y, Stuber T, de Marchi SF, Rexhaj E, Sartori C, Scherrer U, Rimoldi SF. Pulmonary artery pressure and cardiac function in
                   children and adolescents after rapid ascent to 3,450 m. Am J Physiol Heart Circ Physiol 2012;302:H2646-53.
               30.  Sartori C, Rimoldi SF, Rexhaj E, Allemann Y, Scherrer U. Epigenetics in cardiovascular regulation. Adv Exp Med Biol 2016;903:55-62.
               31.  Rexhaj E, Bloch J, Jayet PY, Rimoldi SF, Dessen P, Mathieu C, Tolsa JF, Nicod P, Scherrer U, Sartori C. Fetal programming of
                   pulmonary vascular dysfunction in  mice: role of epigenetic mechanisms. Am J Physiol Heart Circ Physiol 2011;301:H247-52.
               32.  de Wijs-Meijler DP, Duncker DJ, Tibboel D, Schermuly RT, Weissmann N, Merkus D, Reiss IKM. Oxidative injury of the pulmonary
                   circulation in the perinatal period: short- and long-term consequences for the human cardiopulmonary system. Pulm Circ 2017;7:55-66.
               33.  Hussain M, Xu C, Ahmad M, Yang Y, Lu M, Wu X, Tang L, Wu X. Notch signaling: linking embryonic lung development and asthmatic
   22   23   24   25   26   27   28   29   30   31   32